CCG258747 | CCG258747 : Inhibitor of GRK2
RATINGS:
Cellular Use: (1 reviews)

In Model Organisms: (1 reviews)
Control Compounds
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
GRK2
  • IC50:18 nM
Inhibitor
up to 10 uM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity over GRK1, GRK5, PKA, and ROCK1 (518-, 83-, >5500-, and >550-fold, respectively) was ass ...
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Kinome-wide selectivity of CCG258747 was evaluated at 1 μM in the scanELECT screen (DiscoverX) consi ...

Potency
Cellular
In Vitro

GRK2

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1124/mol.119.118661

In Vivo Validations

Mouse
Dose: 10 mg/Kg
Route of delivery: Intraperitoneal
Plasma half life: 7 h
Cmax: 1520 nM
Tmax: 0.5 h
Area Under the Curve:: 4970 h*nM

DOI Reference: 10.1124/mol.119.118661

Chemical Information

Molecular Formula C28H27FN4O4
SMILEs O=C(NCc1[nH]nc2ccccc12)c1cc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)ccc1F
InChI InChI=1S/C28H27FN4O4/c29-23-7-5-17(11-22(23)28(34)31-14-25-21-3-1-2-4-24(21)32-33-25)20-9-10-30-13-18(20)15-35-19-6-8-26-27(12-19)37-16-36-26/h1-8,11-12,18,20,30H,9-10,13-16H2,(H,31,34)(H,32,33)/t18-,20-/m0/s1
Molecular weight 502.20 Da
AlogP 4.132800000000003
HBond acceptors 8
HBond donors 3
Atoms 64

References

Cross References

canSARChEMBLBindingDBPDB

Expert Reviews


(on 7 Apr 2025 )
Cellular Use Rating
In Model Organisms
CCG258747 is an indazole analog of paroxetine with highly potent GRK2 inhibitory activity (18 nM in cell-free assay). Potent GRK2 inhibition was also confirmed in a kinase selectivity and profiling assay...
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria